BPC-157 + TB-500
bpc-157-tb-500 appears in 1,406 indexed publications going back to 1982, including 67 in the past twelve months. 17 registered trials appear on ClinicalTrials.gov.
On This Figure
BPC-157 + TB-500 is a blend. These figures combine its components (BPC-157, TB-500), so totals are an upper bound where a single paper covers more than one of them.
Publication history
How much work has been indexed each year, from Europe PMC. Momentum is measured over a trailing twelve months rather than calendar years, so a partial current year never reads as a decline.
Publications per year. The final bar is the current year, still in progress.
| 2015 | 5 |
|---|---|
| 2016 | 8 |
| 2017 | 11 |
| 2018 | 9 |
| 2019 | 6 |
| 2020 | 11 |
| 2021 | 19 |
| 2022 | 12 |
| 2023 | 10 |
| 2024 | 5 |
| 2025 | 19 |
| 2026 | 27 |
Who is looking it up
Monthly readers of the BPC-157 + TB-500 article on English Wikipedia. An independent measure of curiosity, which often moves quite differently from the evidence.
The registered pipeline
Phase distribution across the most recently updated registered trials.
- Recruiting·Phase 2
BPC 157 for Acute Hamstring Muscle Strain Repair
Hudson Biotech · estimated completion 2027-02-14
- Status unknown·Phase 1
PCO-02 - Safety and Pharmacokinetics Trial
PharmaCotherapia d.o.o. · completed 2016-02
- Not yet recruiting·Phase 2
Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction
Beijing Northland Biotech. Co., Ltd. · estimated completion 2027-08-17
- Recruiting·Phase 1
TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD
Hudson Biotech · estimated completion 2027-02-14
- Recruiting·Phase 3
ReGenTree, LLC · completed 2026-04-30
- Terminated·Phase 3
ReGenTree, LLC · completed 2019-11-20
Most recent work
The newest indexed records mentioning BPC-157 + TB-500, listed by publication date. Titles are shown as published and link to their source. Inclusion here is a record of what exists, not a judgement of what it shows.
- 2026-08-01·Clinical science (London, England : 1979)
Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway
Ouyang X, Long Z, Xu X et al.
- 2026-07-27·The Analyst
Mazzarino M, Colpaert T, Deventer K et al.
- 2026-07-10·Experimental eye research
Banga L, Shawky M, Ebrahim F et al.
- 2026-07-01·Current sports medicine reports
Effects of Supplementation in Masters Athletes and Older Adults: A Narrative Review
Nguyen C, Allen MR, Hornburg K et al.
- 2026-07-01·Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Li YX, Chen CL, Zheng SD et al.
- 2026-06-01·Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
Vukoja I, Vlainic J, Francina M et al.
- 2026-06-01·Investigative ophthalmology & visual science
Ebrahim AS, Liu L, Carion TW et al.
- 2026-05-30·Pharmaceuticals (Basel, Switzerland)
Smoday IM, Vukovic V, Oroz K et al.
BPC-157 + TB-500 available from Polaris Research
Supplied as research materials for laboratory use. Free express delivery Australia wide.
Sources
Publication data from Europe PMC. Clinical trial data from ClinicalTrials.gov, U.S. National Library of Medicine. Public attention from Wikimedia pageview data. Evidence grades from reptides.co. We report counts and dates from these sources and link every record to its origin, we do not summarise findings. Last synced 2026-08-02.